المؤلفون: Peter Ansell, Lisa Roberts-Rapp, Priya Kumthekar, Ho-Jin Lee, Marta Penas-Prado, Louis B. Nabors, David A. Reardon, Hao Xiong, Earle Bain, Erica Gomez, David Maag, Kyriakos P. Papadopoulos, Martin J. van den Bent, Tobias Walbert, Nicholas Butowski, Andrew B. Lassman, Ryan Merrell, Zarnie Lwin, Hui K Gan, Kyle D. Holen, Helen Wheeler, Andrew M. Scott, Tom Mikkelsen, John Simes

المساهمون: Neurology

المصدر: Neuro-Oncology, 21(1), 106-114. Oxford University Press
Neuro-Oncology

مصطلحات موضوعية: Male, Oncology, Cancer Research, Cell, Depatuxizumab mafodotin, Cohort Studies, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, EGFR amplification, Tissue Distribution, Epidermal growth factor receptor, biology, Brain Neoplasms, Middle Aged, Prognosis, rGBM, 3. Good health, ErbB Receptors, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Antibody, medicine.drug, Adult, medicine.medical_specialty, Antibody-drug conjugate, depatux-m, Maximum Tolerated Dose, Clinical Investigations, Antibodies, Monoclonal, Humanized, Young Adult, 03 medical and health sciences, Pharmacokinetics, SDG 3 - Good Health and Well-being, Internal medicine, Multicenter trial, Temozolomide, Humans, Aged, business.industry, Gene Amplification, antibody–drug conjugate, International Agencies, ABT-414, biology.protein, Neurology (clinical), Neoplasm Recurrence, Local, Glioblastoma, business, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b826fa234de182c56cd50693251c3b03Test
https://pure.eur.nl/en/publications/a6d634d2-cf77-41a8-85f8-99e93079ff3fTest

المؤلفون: Pim J. French, Joana Brilhante, Martin J. van den Bent, P. Ansell, Paul Sanghera, Marion Smits, Enrico Franceschi, Sarah Nuyens, Jyotirmoy Dey, Marica Eoli, Hendrikus J. Dubbink, Juan Manuel Sepúlveda, Corneel Coens, Olivier Chinot, Vassilis Golfinopoulos, Paul Clement, Michael Weller, Annemiek M E Walenkamp, Jim Looman, Jean-Sebastian Frenel, Maarten Spruyt, Thierry Gorlia, Scott Krause, Nicolas Whenham, Filip de Vos

المساهمون: Department of Neurology, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Department of Medical Oncology (AUSL di Bologna), Azienda Unità Sanitaria Locale di Bologna (AUSL), Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service de Neuro-oncologie, Assistance Publique - Hôpitaux de Marseille (APHM), University hospital of Zurich [Zurich], Quality of Life Department, European Organisation for Research and Treatment of Cancer, EORTC, European Organization for Research and Treatment of Cancer DataCenter, Guided Treatment in Optimal Selected Cancer Patients (GUTS), University of Zurich, Van Den Bent, Martin, Neurology, Radiology & Nuclear Medicine, Pathology

المصدر: Neuro-Oncology
Neuro-Oncology, 2019, ⟨10.1093/neuonc/noz222⟩
Neuro-Oncology, 22(5), 684-693. Oxford University Press
Neuro-Oncology, Oxford University Press (OUP), 2019, ⟨10.1093/neuonc/noz222⟩

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_treatment, [SDV]Life Sciences [q-bio], MONOTHERAPY, Phases of clinical research, Depatuxizumab mafodotin, 0302 clinical medicine, PROGNOSTIC-FACTORS, Lomustine, Clinical endpoint, 1306 Cancer Research, ComputingMilieux_MISCELLANEOUS, 0303 health sciences, Brain Neoplasms, Hazard ratio, GLIOMAS, Corrigenda, 3. Good health, ErbB Receptors, 2728 Neurology (clinical), 030220 oncology & carcinogenesis, TRIAL, 2730 Oncology, TYROSINE KINASE INHIBITOR, MGMT, Adjuvant, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, depatux-m, EGFR, BEVACIZUMAB, Clinical Neurology, Clinical Investigations, 610 Medicine & health, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, recurrent, Antibody drug conjugate, Internal medicine, medicine, Temozolomide, AcademicSubjects/MED00300, Humans, Adverse effect, COMBINATION, Antineoplastic Agents, Alkylating, 030304 developmental biology, Science & Technology, business.industry, glioblastoma, EFFICACY, 10040 Clinic for Neurology, Editor's Choice, AcademicSubjects/MED00310, Neurology (clinical), Neurosciences & Neurology, business

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1976fb2477ebef1d1c2eca258ef103Test
http://europepmc.org/articles/PMC7229258Test